Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Becky Campbell discount, or call them directly and let them know youre a part of the Dr
Individual components of the 3P-MACE were secondary endpoints, along with additional outcomes: hospitalization for heart failure (HHF), hospitalization for any cardiovascular disease (CVD), and revascularization procedures
Ken December 13, 2023, 3:27pm 4 Opened this post, then went to Reddit and was served an Ozempic ad for the first time I can recall
Tirzepatide (10mg-30mg), Dual-Action Incretin Co-Agonist Engineered Engagement of GIP and GLP-1 Receptors Introduction Engineered Engagement of GIP and GLP-1 Receptors Tirzepatide is a 39-residue synthetic peptide engineered to simultaneously activate two distinct incretin receptors, the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), within a single molecular scaffold
At 2.5 mg, you need 12.5 units
